Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Irie

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 1, 1991
[Clinical experience of extracorporeal shock wave lithotripsy for cystine calculi]S Kubo, T Arakawa, H Nakajo, et al.
International Journal of Immunopathology and Pharmacology|April 10, 2010
Identification of SARS-COV spike protein-derived and HLA-A2-restricted human CTL epitopes by using a new muramyl dipeptidederivative adjuvantY-Z Chen, G Liu, S Senju, et al.
Biochemistry|November 26, 1999
Alpha 3 beta 1 adhesion to laminin-5 and invasin: critical and differential role of integrin residues clustered at the boundary between alpha 3 N-terminal repeats 2 and 3X P Zhang, W Puzon-McLaughlin, A Irie, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Oligonucleotide modulation of multidrug resistanceD Y Bouffard, T Ohkawa, H Kijima, et al.
The Journal of Biological Chemistry|July 11, 1997
Defining the topology of integrin alpha5beta1-fibronectin interactions using inhibitory anti-alpha5 and anti-beta1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the alpha5 subunitA P Mould, J A Askari, S i Aota, et al.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1997
Anti-oncogene ribozymes for cancer gene therapyA Irie, H Kijima, T Ohkawa, et al.
Gene Therapy|March 1, 2000
Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cellsT Suzuki, B Anderegg, T Ohkawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2000
The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calciumS Strobl, C Fernandez-Catalan, M Braun, et al.
Molecular Urology|November 3, 2001
Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in miceT Uchida, J P Gao, C Wang, et al.
British Journal of Cancer|December 24, 2010
Identification of HLA-A2-restricted CTL epitopes of a novel tumour-associated antigen, KIF20A, overexpressed in pancreatic cancerK Imai, S Hirata, A Irie, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 1, 1991
[Clinical experience of extracorporeal shock wave lithotripsy for cystine calculi]S Kubo, T Arakawa, H Nakajo, et al.
International Journal of Immunopathology and Pharmacology|April 10, 2010
Identification of SARS-COV spike protein-derived and HLA-A2-restricted human CTL epitopes by using a new muramyl dipeptidederivative adjuvantY-Z Chen, G Liu, S Senju, et al.
Biochemistry|November 26, 1999
Alpha 3 beta 1 adhesion to laminin-5 and invasin: critical and differential role of integrin residues clustered at the boundary between alpha 3 N-terminal repeats 2 and 3X P Zhang, W Puzon-McLaughlin, A Irie, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Oligonucleotide modulation of multidrug resistanceD Y Bouffard, T Ohkawa, H Kijima, et al.
The Journal of Biological Chemistry|July 11, 1997
Defining the topology of integrin alpha5beta1-fibronectin interactions using inhibitory anti-alpha5 and anti-beta1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the alpha5 subunitA P Mould, J A Askari, S i Aota, et al.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1997
Anti-oncogene ribozymes for cancer gene therapyA Irie, H Kijima, T Ohkawa, et al.
Gene Therapy|March 1, 2000
Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cellsT Suzuki, B Anderegg, T Ohkawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2000
The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calciumS Strobl, C Fernandez-Catalan, M Braun, et al.
Molecular Urology|November 3, 2001
Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in miceT Uchida, J P Gao, C Wang, et al.
British Journal of Cancer|December 24, 2010
Identification of HLA-A2-restricted CTL epitopes of a novel tumour-associated antigen, KIF20A, overexpressed in pancreatic cancerK Imai, S Hirata, A Irie, et al.
Pageof 11